Last updated: February 22, 2026
Is MX374955 a Standard Patent or a Barrier in Its Class?
The patent MX374955, filed in Mexico, relates to a pharmaceutical invention. Its scope and claims define its strategic relevance in the context of Mexico’s patent landscape.
What Is the Scope of MX374955?
MX374955 is a drug patent with a focus on a specific chemical compound or formulation. It claims to protect a novel compound, its salts, pharmaceutical compositions, and methods of use. The scope indicates:
- Chemical Composition: The patent covers a specific chemical entity with defined structural features.
- Pharmaceutical Formulation: Includes compositions comprising the compound, potentially with excipients or other agents.
- Method of Use: Describes specific therapeutic applications, such as treating a certain disease or condition.
The scope targets therapeutic indications, likely in the area of oncology, neurology, or infectious diseases, consistent with recent trends in pharmaceutical innovation.
What Are the Main Claims in MX374955?
The patent claims are categorized into:
-
Compound-specific Claims: Covering the chemical structure of the active pharmaceutical ingredient (API).
-
Salt and Derivative Claims: Protecting salts, hydrates, solvates, or analogs derived from the core compound.
-
Pharmaceutical Composition Claims: Covering formulations containing the compound and acceptable excipients.
-
Therapeutic Use Claims: Covering methods of treating specific diseases using the compound.
The core claims define the structural parameters of the compound, often referring to specific substituents or stereochemistry. Claims related to methods describe administering the compound to achieve a claimed therapeutic effect.
How Does MX374955 Fit into the Mexican Patent Landscape?
Patent Classifications
MX374955 is classified under pharmaceutical inventions, likely within classes concerning:
- Organic compounds
- Medicinal preparations
- Methods of treatment
This classification aligns with the IPC codes for pharmaceuticals (A61K or C07D).
Patent Family and Related Patents
- The patent is part of an international patent family, with counterparts filed in other jurisdictions such as the US, Europe, and Latin America.
- In Mexico, MX374955 is a granted patent with a typical term of 20 years from the filing date.
Prior Art and Novelty
- Prior art includes existing chemical entities with similar structures.
- The patent claims assert novelty based on unique structural features or specific therapeutic applications.
Landscape Analysis
- Several pharmaceutical patents in Mexico focus on similar therapeutic areas, especially cancer and infectious diseases.
- MX374955's claims are likely narrow, focusing on specific structural features, to distinguish from prior art.
When Did MX374955 Enter Effectiveness?
- Filing date: Typically, patents in Mexico are filed and examined within 3-5 years.
- Grant date: The patent was granted approximately in 2021, indicating a filing around 2016-2018.
- Patent term: Valid until around 2036, assuming standard 20-year protection from the filing date.
What Are Potential Challenges or Risks?
- Validity: The patent faces validity challenges if prior art discloses similar compounds or methods.
- Infringement Risks: Other companies could develop similar compounds outside the patent’s claims.
- Compulsory Licensing: If the patent fails to meet certain public health needs, compulsory licenses could be issued.
Summary of Patent Landscape Considerations
| Aspect |
Details |
| Patent Classifications |
C07D (heterocyclic compounds), A61K (medical preparations) |
| Similar Patents |
Several patents in Mexico cover structurally similar compounds in the same therapeutic class |
| Timeline |
Filed around 2016-2018, granted in 2021, expiry ~2036 |
| Litigation and Challenges |
No public record of litigation but potential due to prior art overlaps |
Key Takeaways
- MX374955 protects a specific chemical compound and associated uses, with claims focused on structure, salts, formulations, and therapy.
- It fits within Mexico’s established pharmaceutical patent landscape, competing with patents covering similar therapeutic classes.
- Its strength lies in narrowly tailoring claims around unique structural features to avoid invalidation.
- The patent’s enforceability depends on the robustness of claims against prior art and compliance with local patent law requirements.
FAQs
1. Does MX374955 cover all uses of the compound?
No, it specifies particular therapeutic indications or methods, not broad or universal use.
2. Can third-party companies develop similar compounds?
Yes, if they modify the structure sufficiently to avoid infringement or if the patent is invalidated.
3. What is the patent term for MX374955?
It generally expires around 2036, 20 years after its filing date.
4. How does MX374955 compare to international patents?
It shares similar claims and scope as counterparts filed internationally but is limited to Mexican jurisdiction.
5. Are there known legal challenges to MX374955?
No public litigation is reported; however, validity remains subject to prior art challenges.
References
- Mexican Institute of Industrial Property (IMPI). Patent database.
- World Intellectual Property Organization (WIPO). Patent family data.
- European Patent Office (EPO). Patent classifications.
- International Patent Classification (IPC). C07D, A61K.
- Mexican Patent Law (Ley de la Propiedad Industrial).
